NCT00857285
Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
See it on ClinicalTrials.gov ↗130 people
43.1%
56.9%
56 womenmiddle line = equal numbers74 men
- Phase
- PHASE3
- Paid for by
- Daiichi Sankyo
- Finished
- 2003-09
- Health conditions
- Essential Hypertension
- Who could join
- Anyone
- Ages
- 20 Years – 75 Years
- Average age
- mean 48.98 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Other 100%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“History or clinical evidence of cerebrovascular, gastrointestinal, hematological, hepatic disease, myocardial infarction, or severe liver disorder”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Significant cardiovascular disease”
- No diabetes
Women with diabetes were turned away.
“Clinical evidence of renal disease, poorly controlled diabetes, known malabsorption syndromes, psychiatric/emotional problems”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Clinical evidence of renal disease, poorly controlled diabetes, known malabsorption syndromes, psychiatric/emotional problems”
- No cancer
Women with current or past cancer were turned away.
“Malignant hypertension”
Study titles and rules are shown in their original English.